Cardiac tertiary immune niches drive immune activation in immune checkpoint inhibitor myocarditis
Science Advances · 2026
DOI: 10.1126/sciadv.aed8359 ↗At a glance
Journal article in Science Advances, 2026. Written by Carly C Tymm and 5 co-authors. Institution: Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA. Major MEDLINE topics: Myocarditis, Immune Checkpoint Inhibitors, Myocardium, Tertiary Lymphoid Structures. 55 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (original language)
Immune checkpoint inhibitor (ICI) myocarditis is a rare but frequently fatal immune-related adverse event of cancer immunotherapy. Understanding the mechanisms of this toxicity is critical to balancing treatment with maintenance of antitumor immunity. Using integrated spatial and single-cell analyses in a pharmacological murine model, we identified regional infiltration of Ly6C + monocytes and PD-1 + CD8 + T cells in the heart that organize into fibroblast-rich immune structures, which we term tertiary T cell niches (TTCNs). TTCNs serve as hubs for T cell activation, sharing features of tertiary lymphoid structures. A TTCN gene signature was strongly enriched in cardiac tissue from patients with ICI myocarditis. Complementary T cell receptor analyses revealed clonal expansion of cardiac T cells following ICI treatment. We further identified TTCN-associated cytokines and structural proteins as candidate therapeutic targets to reduce myocardial inflammation while considering tumor control. Together, these findings suggest that cardiac tertiary immune structures play a central role in ICI myocarditis and highlight pathways that could mitigate ICI cardiotoxicity.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA.
- Division of Rheumatology, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA.
- Herbert Irvine Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA.
ORCID profiles: Carly C Tymm, Matthieu Paiola, Xizi Hu, Robert Winchester, Adam Mor
Funding
- NIAID NIH HHS
- NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Cite
APA
Tymm, C. C., Paiola, M., Bukhari, S., Hu, X., Winchester, R., & Mor, A. (2026). Cardiac tertiary immune niches drive immune activation in immune checkpoint inhibitor myocarditis. Science Advances. https://doi.org/10.1126/sciadv.aed8359
Vancouver
Tymm CC, Paiola M, Bukhari S, Hu X, Winchester R, Mor A. Cardiac tertiary immune niches drive immune activation in immune checkpoint inhibitor myocarditis. Science Advances. 2026. doi:10.1126/sciadv.aed8359
BibTeX
@article{Tymm2026,
author = {Tymm, Carly C and Paiola, Matthieu and Bukhari, Shoiab and Hu, Xizi and Winchester, Robert and Mor, Adam},
title = {Cardiac tertiary immune niches drive immune activation in immune checkpoint inhibitor myocarditis},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aed8359}
}
EUVIMED